文献速递心外重症与机械循环支持

左心室辅助装置植入同期三尖瓣手术的临床影响

Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation.
PubMed 文献 · J Heart Lung Transplant · 2020-05-19

基于INTERMACS数据库2008至2017年连续流LVAD成人患者,比较同期行三尖瓣手术与未行手术者。结果显示TVP与生存获益无关,中重度TR患者合并TVP死亡率增加,且出血、心律失常、卒中风险升高,生活质量无改善。

要点

  • TVP与轻、中、重度TR患者的生存获益均无关。
  • 中重度TR患者同期TVP与死亡率增加相关。
  • TVP与出血、心律失常、卒中风险增加相关,QOL无改善。

核心结论

  • LVAD植入同期TVP与生存或生活质量改善无关,中重度TR患者中与不良事件风险增加相关。

研究设计与样本

  • 基于INTERMACS数据库的回顾性队列研究,纳入2008至2017年接受连续流LVAD的成人患者,按TR程度分层比较同期TVP与未行TVP者。

主要发现

  • TVP率随TR严重程度增加:轻度8.6%、中度18.0%、重度43.9%。
  • TVP与轻度(aHR 0.97,95%CI 0.79-1.19,p=0.75)、中度(aHR 1.03,95%CI 0.88-1.20,p=0.72)、重度(aHR 1.20,95%CI 0.98-1.48,p=0.08)TR的生存获益均无关。
  • 中重度TR合并TVP者死亡率增加(log-rank p<0.01,aHR 1.13,95%CI 1.00-1.27,p=0.04)。
  • 校正TR严重程度后,TVP与出血、心律失常、卒中风险增加相关(各p<0.01),生活质量无改善(p>0.05)。

临床怎么用

  • LVAD植入时对轻中度TR行同期TVP应谨慎权衡,尤其关注中重度TR患者的不良事件风险。

局限性

  • 研究为回顾性注册分析,TVP组与未TVP组间可能存在选择偏倚,无法排除混杂因素对结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tricuspid regurgitation (TR) is common in patients with end-stage heart failure receiving left ventricular assist devices (LVADs), but the benefit of concomitant tricuspid valve procedures (TVPs) remains uncertain. This study examined the impact of TVP at the time of LVAD implantation on clinical outcomes and quality of life (QOL) metrics. METHODS: We included adult patients in the Interagency Registry for Mechanical Circulatory Support database with various degrees of TR who received continuous-flow LVADs from 2008 to 2017. Patients undergoing concomitant TVP were compared with those without the intervention in a stratified analysis. Descriptive analyses, survival analyses, and Andersen‒Gill hazard models were used as appropriate to examine associations with clinical and patient-centered QOL outcomes. RESULTS: Our analysis included 8,263 (53.1%) mild, 4,252 (33.3%) moderate, and 2,100 (13.5%) severe TR cases. TVP rate increased with severity: 8.6% of mild, 18.0% of moderate, and 43.9% of severe cases. TVP was not associated with survival benefit in cases of mild (adjusted hazard ratio [aHR]: 0.97, 95% CI: 0.79-1.19, p = 0.75), moderate (aHR: 1.03, 95% CI: 0.88-1.20, p = 0.72), or severe (aHR: 1.20, 95% CI: 0.98-1.48, p = 0.08) TR. For patients with combined moderate or severe TR, TVP was associated with increased mortality (log-rank p < 0.01, aHR: 1.13, 95% CI: 1.00-1.27, p = 0.04). After adjusting for TR severity, TVP was associated with increased risk of bleeding, arrhythmia, and stroke (p < 0.01 each) and no improvements in QOL (p > 0.05). CONCLUSIONS: TVP at the time of LVAD implantation was not associated with either improved survival or QOL, and there were associations with increased risk of adverse events among patients with moderate and severe TR.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Mullan C, Caraballo C, Ravindra NG, et al. Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation. J Heart Lung Transplant. 2020. PMID: 32593561. doi:10.1016/j.healun.2020.05.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。